Skip to main content
  1. Home
  2. Emerging Tech
  3. Legacy Archives

Overstock.com plans to accept Bitcoin in 2014

Add as a preferred source on Google

Overstock.com CEO Patrick Byrne says the online retailer plans to start accepting Bitcoin as a payment method during 2014, and possibly within the next four months. While a number of services, from Reddit to Virgin Galactic, already accept Bitcoin payments, Overstock.com would be the biggest retailer yet to make the move.

Check the small print before diving into Overstock.com’s range of furnishings, fashion and electronics, though. The site will convert Bitcoin to US dollars on a daily basis, so your digital currency may not go as far (or much further) than you were expecting. We’ve recently reported on Bitcoin’s volatile market value, as well as the other emerging alternative currencies that have made these altcoins one of the biggest stories of 2013.

Recommended Videos

“I think we’ll pick up market share,” Byrne told the Los Angeles Times, “the market share of people who’d prefer to pay in Bitcoin, with an honest currency.” He said that the decision is “also philosophical, part and parcel with my belief in a limited government — that if you want limited government you can’t give it power to expand the monetary base.”

Items on Overstock.com will still be priced in dollars, but shoppers will have the option to pay in Bitcoins once they reach the checkout, where the most up-to-date exchange rate will be displayed. This matches the policies of other retailers, such as Bitcoinstore.com, as they look to protect themselves against sudden jumps in Bitcoin’s value.

News about Overstock.com’s plans saw the company’s shares climb 7.77 percent in the day’s NASDAQ trading. The retailer pulled in just over $1 billion in revenue during the last year. It remains to be seen where Bitcoin’s value and popularity will be once Overstock.com starts accepting it, but it’s another significant development for these fledging digital currencies.

David Nield
Former Contributor
Dave is a freelance journalist from Manchester in the north-west of England. He's been writing about technology since the…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more